Did you know? The total GLP-1 market is projected to reach a potential $200 billion by 2031.
As such, oral solid dose (OSD) formulations are poised to gain significant traction.
This shift demands manufacturing partners with proven expertise in:
💊Specialized potent compound handling
⏳ Modified release technology
🎯 Precise quality control systems
📈 Continuity of supply
https://www.lannettcdmo.com/ad....vanced-formulation-a
Like
Comment
Share
